{"transactions":[{"id":4627300,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-28T12:30:18.000Z","date":"2026-09-24","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":2.76,"value":13800.0,"ownership":{"direct":true},"balance_after":140572,"source":{"system":"sec-edgar","filing":"0001493152-26-044457","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683567/000149315226044457/ownership.xml","form_type":"4"}},{"id":701862,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-07-29T09:14:58.000Z","date":"2026-07-27","kind":"exercise","planned":false,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Right-To-Buy, pursuant to a stock option grant dated August 23, 2013."}],"balance_after":0,"derivative":{"exercise_price":3.13,"exercise_date":"2016-08-23","expiration_date":"2026-08-23","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001493152-26-035122","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226035122/ownership.xml","form_type":"4"}},{"id":701861,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-29T09:14:58.000Z","date":"2026-07-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":5428,"price":3.46,"value":18780.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person exercised the stock options at this time due to their expiration on August 23, 2026. The disposal of shares reported herein represents shares withheld by Anixa Biosciences, Inc. (the \"registrant\") to cover the exercise price of the stock options."}],"balance_after":135572,"source":{"system":"sec-edgar","filing":"0001493152-26-035122","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226035122/ownership.xml","form_type":"4"}},{"id":701860,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-29T09:14:58.000Z","date":"2026-07-27","kind":"exercise","planned":false,"acquired":true,"shares":6000,"price":3.13,"value":18780.0,"ownership":{"direct":true},"balance_after":141000,"source":{"system":"sec-edgar","filing":"0001493152-26-035122","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226035122/ownership.xml","form_type":"4"}},{"id":928362,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-29T08:58:38.000Z","date":"2026-01-28","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.04,"value":30400.0,"ownership":{"direct":true},"balance_after":135000,"source":{"system":"sec-edgar","filing":"0001493152-26-004148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226004148/ownership.xml","form_type":"4"}},{"id":949147,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2026-01-06T19:40:10.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2026."}],"balance_after":25000,"derivative":{"exercise_price":3.18,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-26-000685","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226000685/ownership.xml","form_type":"4"}},{"id":1084406,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-21T08:30:06.000Z","date":"2025-07-18","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":3.39,"value":16950.0,"ownership":{"direct":true},"balance_after":125000,"source":{"system":"sec-edgar","filing":"0001641172-25-020362","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000164117225020362/ownership.xml","form_type":"4"}},{"id":1292387,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-29T10:06:40.000Z","date":"2025-01-28","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":2.82,"value":14100.0,"ownership":{"direct":true},"balance_after":120000,"source":{"system":"sec-edgar","filing":"0001493152-25-004108","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225004108/ownership.xml","form_type":"4"}},{"id":1317634,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2025-01-03T17:40:32.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2025."}],"balance_after":25000,"derivative":{"exercise_price":2.37,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-25-000313","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225000313/ownership.xml","form_type":"4"}},{"id":1448436,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-26T13:26:12.000Z","date":"2024-07-26","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":3.09,"value":15450.0,"ownership":{"direct":true},"balance_after":115000,"source":{"system":"sec-edgar","filing":"0001493152-24-029191","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224029191/ownership.xml","form_type":"4"}},{"id":1575813,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-15T14:15:37.000Z","date":"2024-03-15","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.63,"value":36300.0,"ownership":{"direct":true},"balance_after":110000,"source":{"system":"sec-edgar","filing":"0001493152-24-010060","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224010060/ownership.xml","form_type":"4"}},{"id":1679560,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-01-16T19:08:30.000Z","date":"2024-01-12","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2024."}],"balance_after":25000,"derivative":{"exercise_price":4.39,"expiration_date":"2034-01-12","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-24-002531","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224002531/ownership.xml","form_type":"4"}},{"id":2071074,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-01-04T20:50:37.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2023."}],"balance_after":25000,"derivative":{"exercise_price":4.19,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-23-000418","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223000418/ownership.xml","form_type":"4"}},{"id":2227901,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T16:13:21.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":39473,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") is the economic equivalent of one share of Baudax Bio, Inc. (the \"Company\") common stock, and may be settled, at the Company's option, in cash, shares of common stock, or a combination thereof. The RSUs vest in full on June 15, 2023, subject to continued service with the Company through the vesting date. Upon vesting, if settled in cash, each RSU will entitle the grantee to a cash-payment equal to the \"Fair Market Value\" (as defined in the Company's 2019 Equity Incentive Plan) of one share of the Company's common stock on the vesting date."}],"balance_after":41942,"source":{"system":"sec-edgar","filing":"0001062993-22-015132","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683567/000106299322015132/form4.xml","form_type":"4"}},{"id":2338852,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-03-11T16:15:26.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning March 31, 2022."}],"balance_after":100000,"derivative":{"exercise_price":2.74,"expiration_date":"2032-03-10","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-22-006623","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222006623/ownership.xml","form_type":"4"}},{"id":2624535,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-27T09:56:43.000Z","date":"2021-07-23","kind":"purchase","acquired":true,"shares":19000,"price":4.33,"value":82270.0,"ownership":{"direct":true},"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001493152-21-017817","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315221017817/ownership.xml","form_type":"4"}},{"id":2632673,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-16T11:22:10.000Z","date":"2021-07-15","kind":"purchase","acquired":true,"shares":20000,"price":3.9,"value":78000.0,"ownership":{"direct":true},"balance_after":81000,"source":{"system":"sec-edgar","filing":"0001493152-21-017005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315221017005/ownership.xml","form_type":"4"}},{"id":2687919,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-06-02T17:00:52.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning June 30, 2021."}],"balance_after":30000,"derivative":{"exercise_price":4.02,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-21-013457","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315221013457/ownership.xml","form_type":"4"}},{"id":2714510,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-13T17:32:05.000Z","date":"2021-05-11","kind":"purchase","acquired":true,"shares":10000,"price":0.82,"value":8200.0,"ownership":{"direct":true},"balance_after":86452,"source":{"system":"sec-edgar","filing":"0001192482-21-000422","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683567/000119248221000422/edgar.xml","form_type":"4"}},{"id":2744429,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-20T13:27:12.000Z","date":"2021-04-20","kind":"purchase","acquired":true,"shares":10000,"price":3.91,"value":39100.0,"ownership":{"direct":true},"balance_after":61000,"source":{"system":"sec-edgar","filing":"0001493152-21-009223","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315221009223/ownership.xml","form_type":"4"}},{"id":2752955,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-08T19:21:16.000Z","date":"2021-04-07","kind":"grant","acquired":true,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on April 7, 2022."}],"balance_after":83333,"derivative":{"exercise_price":1.24,"expiration_date":"2031-04-07","underlying":"Common Stock","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001192482-21-000332","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683567/000119248221000332/edgar.xml","form_type":"4"}},{"id":2752954,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-08T19:21:16.000Z","date":"2021-04-07","kind":"grant","acquired":true,"shares":56452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All shares of common stock are represented by unvested restricted stock units that will vest on April 7, 2022. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":76452,"source":{"system":"sec-edgar","filing":"0001192482-21-000332","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683567/000119248221000332/edgar.xml","form_type":"4"}},{"id":2772555,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T15:56:49.000Z","date":"2021-03-25","kind":"purchase","acquired":true,"shares":10000,"price":4.8,"value":48000.0,"ownership":{"direct":true},"balance_after":51000,"source":{"system":"sec-edgar","filing":"0001493152-21-006789","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315221006789/ownership.xml","form_type":"4"}},{"id":3049967,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-21T16:25:30.000Z","date":"2020-08-20","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the shares of common stock are represented by restricted stock units that will vest 50% on each of August 20, 2021 and August 20, 2022, subject to continued service through the applicable vesting date."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001192482-20-000693","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683567/000119248220000693/edgar.xml","form_type":"4"}},{"id":3056601,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-08-17T16:06:04.000Z","date":"2020-08-13","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning August 31, 2020."}],"balance_after":30000,"derivative":{"exercise_price":2.68,"expiration_date":"2030-08-13","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001513162-20-000170","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316220000170/primary_doc.xml","form_type":"4"}},{"id":3214638,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-12T13:38:20.000Z","date":"2020-03-12","kind":"purchase","acquired":true,"shares":10000,"price":1.84,"value":18400.0,"ownership":{"direct":true},"balance_after":41000,"source":{"system":"sec-edgar","filing":"0001513162-20-000048","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316220000048/primary_doc.xml","form_type":"4"}},{"id":3219275,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-10T14:54:17.000Z","date":"2020-03-06","kind":"purchase","acquired":true,"shares":10000,"price":2.71,"value":27100.0,"ownership":{"direct":true},"balance_after":31000,"source":{"system":"sec-edgar","filing":"0001513162-20-000042","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316220000042/primary_doc.xml","form_type":"4"}},{"id":3307015,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-21T11:45:50.000Z","date":"2020-01-17","kind":"purchase","acquired":true,"shares":10000,"price":3.53,"value":35300.0,"ownership":{"direct":true},"balance_after":21000,"source":{"system":"sec-edgar","filing":"0001513162-20-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316220000022/primary_doc.xml","form_type":"4"}},{"id":3388948,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-10-24T19:24:33.000Z","date":"2019-10-23","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning November 30, 2019."}],"balance_after":45000,"derivative":{"exercise_price":3.87,"expiration_date":"2029-10-23","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001513162-19-000223","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000223/primary_doc.xml","form_type":"4"}},{"id":3409480,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2019-09-20T16:17:30.000Z","date":"2019-09-20","kind":"grant","acquired":true,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was originally granted on January 3, 2017 and vests and become exercisable in four (4) equal installments on each March 31, 2017, June 30, 2017, September 30, 2017 and December 31, 2017."}],"balance_after":12000,"derivative":{"exercise_price":5.3,"expiration_date":"2022-09-22","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001513162-19-000209","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000209/primary_doc.xml","form_type":"4"}},{"id":3409479,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2019-09-20T16:17:30.000Z","date":"2019-09-20","kind":"disposition_to_issuer","acquired":false,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was originally granted on January 3, 2017 and vests and become exercisable in four (4) equal installments on each March 31, 2017, June 30, 2017, September 30, 2017 and December 31, 2017."}],"balance_after":0,"derivative":{"exercise_price":0.67,"expiration_date":"2022-09-22","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001513162-19-000209","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000209/primary_doc.xml","form_type":"4"}},{"id":3409478,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2019-09-20T16:17:30.000Z","date":"2019-09-20","kind":"grant","acquired":true,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was originally granted on August 23, 2016 and vested 50% on September 30, 2016 and 50% on December 31, 2016."}],"balance_after":6000,"derivative":{"exercise_price":3.13,"expiration_date":"2022-09-22","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001513162-19-000209","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000209/primary_doc.xml","form_type":"4"}},{"id":3409477,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2019-09-20T16:17:30.000Z","date":"2019-09-20","kind":"disposition_to_issuer","acquired":false,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was originally granted on August 23, 2016 and vested 50% on September 30, 2016 and 50% on December 31, 2016."}],"balance_after":0,"derivative":{"exercise_price":0.67,"expiration_date":"2022-09-22","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001513162-19-000209","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000209/primary_doc.xml","form_type":"4"}},{"id":3548200,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-26T12:58:40.000Z","date":"2019-04-26","kind":"purchase","acquired":true,"shares":10000,"price":4.28,"value":42800.0,"ownership":{"direct":true},"balance_after":11000,"source":{"system":"sec-edgar","filing":"0001513162-19-000113","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000113/primary_doc.xml","form_type":"4"}},{"id":3795515,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-10-09T19:10:04.000Z","date":"2018-10-08","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2010 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning October 31, 2018."}],"balance_after":45000,"derivative":{"exercise_price":5.29,"expiration_date":"2028-10-08","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001513162-18-000253","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316218000253/primary_doc.xml","form_type":"4"}},{"id":4214208,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2017-09-08T18:49:45.000Z","date":"2017-09-06","kind":"grant","acquired":true,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was originally granted on January 3, 2017 and vests and become exercisable in four (4) equal installments on each March 31, 2017, June 30, 2017, September 30, 2017 and December 31, 2017."}],"balance_after":12000,"derivative":{"exercise_price":0.67,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001513162-17-000256","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000256/primary_doc.xml","form_type":"4"}},{"id":4214207,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2017-09-08T18:49:45.000Z","date":"2017-09-06","kind":"disposition_to_issuer","acquired":false,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was originally granted on January 3, 2017 and vests and become exercisable in four (4) equal installments on each March 31, 2017, June 30, 2017, September 30, 2017 and December 31, 2017."}],"balance_after":0,"derivative":{"exercise_price":5.3,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001513162-17-000256","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000256/primary_doc.xml","form_type":"4"}},{"id":4214206,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2017-09-08T18:49:45.000Z","date":"2017-09-06","kind":"grant","acquired":true,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was originally granted on August 23, 2016 and vested 50% on September 30, 2016 and 50% on December 31, 2016."}],"balance_after":6000,"derivative":{"exercise_price":0.67,"expiration_date":"2026-08-23","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001513162-17-000256","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000256/primary_doc.xml","form_type":"4"}},{"id":4214205,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2017-09-08T18:49:45.000Z","date":"2017-09-06","kind":"disposition_to_issuer","acquired":false,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was originally granted on August 23, 2016 and vested 50% on September 30, 2016 and 50% on December 31, 2016."}],"balance_after":0,"derivative":{"exercise_price":3.13,"expiration_date":"2026-08-23","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001513162-17-000256","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000256/primary_doc.xml","form_type":"4"}},{"id":4214204,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-09-08T18:49:45.000Z","date":"2017-09-06","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, pursuant to the ITUS Corporation 2010 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable as follows:  a) 10,000 shares shall be vested and exercisable upon grant; b) 8,888 shares shall vest and become exercisable in eight (8) consecutive quarterly installments of 1,111 shares each on the last day of each fiscal quarter, beginning November 30, 2018 and continuing through August 31, 2019; and c) the remaining 1,112 shares shall vest and become exercisable on November 30, 2019."}],"balance_after":20000,"derivative":{"exercise_price":0.67,"expiration_date":"2027-09-06","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001513162-17-000256","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000256/primary_doc.xml","form_type":"4"}},{"id":4493476,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":28127,"kind":"person","name":"Baskies Arnold M","position":1,"cik":"0001683567","reported_name":"Baskies Arnold M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-01-11T10:39:01.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, pursuant to the ITUS Corporation 2010 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in four (4) equal installments on each March 31, 2017, June 30, 2017, September 30, 2017 and December 31, 2017."}],"balance_after":12000,"derivative":{"exercise_price":5.3,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001513162-17-000016","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000016/primary_doc.xml","form_type":"4"}}]}